4
Changes in Ownership
Vir Biotechnology, Inc. Filed Acc 0001628280-25-049159
EVP and General Counsel sold 1,365 shares at $5.86 ($8,003)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| de Verneuil Vanina EVP and General Counsel | 2025-11-03 | Sale 10b5-1 | −1,365 | $5.86 | $8,003 | 80,595 | D |
| Open-market sales · 1,365 sh · avg $5.86 · $8,003 | |||||||
Loading xslF345X05/wk-form4_1762303236.xml…